Log In
Print
BCIQ
Print
Print this Print this
 

Recentin, cediranib (AZD2171)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionTyrosine kinase inhibitor (TKI) of VEGFR-1, VEGFR-2 and VEGFR-3
Molecular Target Vascular endothelial growth factor (VEGF) receptor 1 (FLT1) (VEGFR-1) ; Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) (VEGFR-2)
Mechanism of ActionVascular endothelial growth factor (VEGF) inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today